title: EphrinA5-EphA7 complex induces apoptotic cell death via TNFR1.
abstract: A previous study showed that the EphA7 receptor regulates apoptotic cell death during early brain development. In this study, we provide evidence that the EphA7 receptor interacts with death receptors such as tumor necrosis factor receptor 1 (TNFR1) to decrease cell viability. We showed that ephrinA5 stimulates EphA7 to activate the TNFR1-mediated apoptotic signaling pathway. In addition, a pull-down assay using biotinylated ephrinA5-Fc revealed that ephrinA5-EphA7 complexes recruit TNFR1 to form a multi-protein complex. Immunocytochemical staining analysis showed that EphA7 was co-localized with TNFR1 on the cell surface when cells were incubated with ephrinA5 at low temperatures. Finally, both the internalization motif and death domain of TNFR1 was important for interacting with an intracytoplasmic region of EphA7; this interaction was essential for inducing the apoptotic signaling cascade. This result suggests that a distinct multi-protein complex comprising ephrinA5, EphA7, and TNFR1 may constitute a platform for inducing caspase-dependent apoptotic cell death.
authors: Department of Biological Science, Sookmyung Women's University, Seoul, 140-742, Korea.
authors: Haeryung
authors: H
authors: Lee
authors: Eunjeong
authors: E
authors: Park
authors: Yujin
authors: Y
authors: Kim
authors: Soochul
authors: S
authors: Park
mesh_terms: D000818:Animals; D017209:Apoptosis; D016923:Cell Death; D036386:Ephrin-A5 / Q000235:genetics / Q000378:metabolism*; D057809:HEK293 Cells; D006801:Humans; D051379:Mice; D036141:Receptor, EphA7 / Q000235:genetics / Q000378:metabolism*; D047888:Receptors, Tumor Necrosis Factor, Type I / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction; D014162:Transfection
chemical_list: D036386:Ephrin-A5; D047888:Receptors, Tumor Necrosis Factor, Type I; C506236:Tnfrsf1a protein, mouse; D036141:Receptor, EphA7; C581330:epha7 receptor, mouse
references: Trends Neurosci. 2000 Oct;23(10):454-8
references: 11006461
references: Results Probl Cell Differ. 2009;49:63-85
references: 19132322
references: Nat Rev Mol Cell Biol. 2008 Aug;9(8):655-62
references: 18545270
references: Immunity. 1997 Nov;7(5):703-13
references: 9390693
references: Mol Cells. 2012 Jul;34(1):103-8
references: 22661025
references: J Neurosci. 2008 Nov 26;28(48):12700-12
references: 19036963
references: Oncogene. 2005 Jun 16;24(26):4243-56
references: 15782114
references: Exp Neurobiol. 2010 Jun;19(1):49-53
references: 22110341
references: Mol Cell Biol. 2007 Dec;27(23):8113-26
references: 17875921
references: Dev Biol. 2004 Oct 15;274(2):233-44
references: 15385155
references: Nature. 2005 Jun 30;435(7046):1244-50
references: 15902206
references: Cell. 1996 Jan 26;84(2):299-308
references: 8565075
references: Cell Death Differ. 2003 Jan;10(1):45-65
references: 12655295
references: Oncogene. 1995 Jan 5;10(1):97-108
references: 7824284
references: Trends Neurosci. 2000 Jul;23(7):291-7
references: 10856938
references: J Clin Invest. 2008 Jan;118(1):64-78
references: 18079969
references: Immunity. 2004 Sep;21(3):415-28
references: 15357952
references: Immunity. 1996 Apr;4(4):387-96
references: 8612133
references: Cell. 2001 Feb 23;104(4):487-501
references: 11239407
references: Neuron. 2008 Sep 11;59(5):746-58
references: 18786358
references: Cell Death Differ. 2013 Jan;20(1):169-80
references: 22976838